Page last updated: 2024-09-03

etomoxir and ALS - Amyotrophic Lateral Sclerosis

etomoxir has been researched along with ALS - Amyotrophic Lateral Sclerosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Andersen, DC; Baisgaard, AE; Bolther, L; Hald, JL; Huijbers, IJ; Huntjens, P; Kroese, LJ; Kullab, UB; Mørk, K; Nieland, JDV; Oklinski, KE; Pritchard, CEJ; Trabjerg, MS; Warming, N	1

Other Studies

1 other study(ies) available for etomoxir and ALS - Amyotrophic Lateral Sclerosis

Article	Year
Downregulating carnitine palmitoyl transferase 1 affects disease progression in the SOD1 G93A mouse model of ALS. Communications biology, 2021, 04-30, Volume: 4, Issue:1 Topics: Amyotrophic Lateral Sclerosis; Animals; Carnitine O-Palmitoyltransferase; Disease Models, Animal; Disease Progression; Down-Regulation; Enzyme Inhibitors; Epoxy Compounds; Female; Gastrointestinal Microbiome; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mutation; Superoxide Dismutase-1	2021

Article

Year

Downregulating carnitine palmitoyl transferase 1 affects disease progression in the SOD1 G93A mouse model of ALS.

Communications biology, 2021, 04-30, Volume: 4, Issue:1

Topics: Amyotrophic Lateral Sclerosis; Animals; Carnitine O-Palmitoyltransferase; Disease Models, Animal; Disease Progression; Down-Regulation; Enzyme Inhibitors; Epoxy Compounds; Female; Gastrointestinal Microbiome; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mutation; Superoxide Dismutase-1

2021